Trade ANTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
AN2 Therapeutics, Inc. (ANTX) is trading at US$4.85, down 4.34% today as of Oct 7, 16:00 EDT. The company has a market capitalisation of US$219.25M. Over the past 52 weeks, ANTX has traded between US$1.00 and US$7.19. On Syfe you can trade ANTX with $0 commission and add it to your watchlist.
| Previous close | US$5.07 |
|---|---|
| Market cap | US$219.25M |
| 52-week range | US$1.00 – US$7.19 |
| Volume | 365.1K |
| Exchange | US |
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley in 2017 and is headquartered in Menlo Park, CA.
Year: 2022
--Guggenheim Initiates AN2 Therapeutics at Buy With $9 Price Target
Jul 20, 10:45 AM · MT Newswires
AN2 Therapeutics Says Chagas Disease Drug Shows Positive Preclinical, Early Human Data
Jun 4, 12:04 PM · MT Newswires
Correction: Leerink Partners Upgrades AN2 Therapeutics to Outperform From Market Perform, Adjusts Price Target to $9 From $1
May 14, 11:06 AM · MT Newswires
--Leerink Downgrades AN2 Therapeutics to Outperform From Market Perform, Adjusts Price Target to $9 From $1
May 14, 11:01 AM · MT Newswires
AN2 Therapeutics, Inc. (ANTX) stock is trading at US$4.85, -4.34% from the previous close of US$5.07.
The market cap for AN2 Therapeutics, Inc. (ANTX) stock is approximately US$219.25M.
The 52-week high for AN2 Therapeutics, Inc. (ANTX) stock is US$7.19.
The 52-week low for AN2 Therapeutics, Inc. (ANTX) stock is US$1.00.
AN2 Therapeutics, Inc. (ANTX) does not currently pay a dividend.
Stay on top of ANTX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
